Evidence map›Paper›PMID 39882905›Full record

ArticleJournal of bacteriology2025

GlnA3

Sergii Krysenko, Carine Sao Emani, Moritz Bäuerle, Maria Oswald, Andreas Kulik, Christian Meyners, Doris Hillemann, Matthias Merker, Gareth Prosser, Inken Wohlers and 5 more

Abstract read
In one paragraph

Article in Journal of bacteriology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Current Approaches for Genetic Manipulation ofBiotech (Basel (Switzerland)) · 2025
    Review
  3. The ArgR-Regulated ADI Pathway Facilitates the Survival ofInternational journal of molecular sciences · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sergii KrysenkoInterfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), Department of Microbiology and Biotechnology, University of Tübingen, Tübingen, Baden-Württemberg, Germany.ORCID 0000-0002-3739-5857
Carine Sao EmaniMicrobial Interface Biology, Research Center Borstel, Leibniz Lung Center, Borstel, Schleswig-Holstein, Germany.
Moritz BäuerleInterfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), Department of Microbiology and Biotechnology, University of Tübingen, Tübingen, Baden-Württemberg, Germany.
Maria OswaldInterfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), Department of Microbiology and Biotechnology, University of Tübingen, Tübingen, Baden-Württemberg, Germany.
Andreas KulikInterfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), Department of Microbiology and Biotechnology, University of Tübingen, Tübingen, Baden-Württemberg, Germany.
Christian MeynersInstitute of Organic Chemistry and Biochemistry, Technical University Darmstadt, Darmstadt, Hessen, Germany.
Doris HillemannNational Reference Center for Mycobacteria, Research Center Borstel, Leibniz Lung Center, Borstel, Schleswig-Holstein, Germany.
Matthias MerkerEvolution of the Resistome, Research Center Borstel, Leibniz Lung Center, Borstel, Schleswig-Holstein, Germany.
Gareth ProsserMicrobial Interface Biology, Research Center Borstel, Leibniz Lung Center, Borstel, Schleswig-Holstein, Germany.
Inken WohlersData Science, Research Center Borstel, Leibniz Lung Center, Borstel, Schleswig-Holstein, Germany.
Felix HauschInstitute of Organic Chemistry and Biochemistry, Technical University Darmstadt, Darmstadt, Hessen, Germany.
Heike Brötz-OesterheltCluster of Excellence 'Controlling Microbes to Fight Infections', University of Tübingen, Tübingen, Baden-Württemberg, Germany.ORCID 0000-0001-9364-1832
Agnieszka MitulskiInterfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), Department of Microbiology and Biotechnology, University of Tübingen, Tübingen, Baden-Württemberg, Germany.
Norbert Reiling *Microbial Interface Biology, Research Center Borstel, Leibniz Lung Center, Borstel, Schleswig-Holstein, Germany.
Wolfgang Wohlleben *Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), Department of Microbiology and Biotechnology, University of Tübingen, Tübingen, Baden-Württemberg, Germany.ORCID 0000-0003-0692-6034

Funding

Bundesministerium für Bildung und Forschung (BMBF) 16GW0183KBundesministerium für Bildung und Forschung (BMBF) 16GW0253K
6 · The paper itself

Abstract

IMPORTANCE: Upon

Indexed as

Bacterial ProteinsMycobacterium tuberculosisSpermineGene Expression Regulation, BacterialInactivation, MetabolicBacterial ProteinsSpermineGlnA3glutamylationGS-like enzymeinfectionpolyamine metabolismRv3065tuberculosis

Identifiers

PMID39882905
PMCPMC11841054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.